Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardiff LexingtonCDIX -41.90%21 Operating Cash Flow per Share is $-0.16 as of Jun. 2026. GuruFocus rates CDIX with a GF Score™ of 21/100 and a GF Value™ of $0.37 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 520 Healthcare Providers & Services companies, Cardiff Lexington ranks better than 96.54% on this metric.
Cardiff Lexington's operating cash flow per share for the
three
months ended in Jun. 2026 was $-0.04.
Cardiff Lexington's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.16.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 91.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Cardiff Lexington's Operating Cash Flow per Share or its related term are showing as below:
CDIX'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 91.3 Med: 91.45 Max: 91.6
Current: 91.6
During the past 13 years, Cardiff Lexington's highest 3-Year average Operating Cash Flow per Share Growth Rate was 91.60% per year. The lowest was 91.30% per year. And the median was 91.45% per year.
CDIX's 3-Year OCF Growth Rate is ranked better than 96.54% of 520
companies
in the Healthcare Providers & Services industry
Industry Median: 9.6
vs CDIX: 91.60
Cardiff Lexington Operating Cash Flow per Share Related Terms
Cardiff Lexington Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Cardiff Lexington's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardiff Lexington Operating Cash Flow per Share Chart
CDIX vs NIVF, RHEP, XCRT: Operating Cash Flow per Share Comparison
For the Medical Care Facilities subindustry, Cardiff Lexington's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardiff Lexington Price-to-Operating-Cash-Flow vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cardiff Lexington's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Cardiff Lexington's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $-0.16 mean?
Cardiff Lexington (CDIX) has a Operating Cash Flow per Share of $-0.16 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Cardiff Lexington and its competitors. According to the industry distribution chart, Cardiff Lexington ranks #18 out of 520 companies in the Healthcare Providers & Services industry, placing it in the top 3.5%.
Is Cardiff Lexington's Operating Cash Flow per Share too high?
Cardiff Lexington's current Operating Cash Flow per Share is $-0.16. Based on the distribution chart, Cardiff Lexington ranks #18 out of 520 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cardiff Lexington has a GF Score™ of 21/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cardiff Lexington's Operating Cash Flow per Share compare to NIVF and RHEP?
According to the Healthcare Providers & Services industry distribution chart, Cardiff Lexington ranks #18 out of 520 companies for Operating Cash Flow per Share. This places Cardiff Lexington in the top 4% of its industry — outperforming the majority of peers. The industry median Operating Cash Flow per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Healthcare Providers & Services company?
The median Operating Cash Flow per Share among Healthcare Providers & Services companies is 9.60, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Cardiff Lexington and its competitors. For the Healthcare Providers & Services industry, the median Operating Cash Flow per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardiff Lexington's current Operating Cash Flow per Share is $-0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiff Lexington stock overvalued right now?
Based on GuruFocus' analysis, Cardiff Lexington (CDIX) is currently considered Possible Value Trap. The stock's GF Value™ is $0.37, compared to a current price of $0.12 — trading 68.6% below its estimated fair value. The current Operating Cash Flow per Share is $-0.16. Cardiff Lexington's overall GF Score™ is 21/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Cardiff Lexington (CDIX), the current Operating Cash Flow per Share is $-0.16 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardiff Lexington (CDIX) Overvalued in 2026?
Based on GuruFocus' analysis, Cardiff Lexington stock appears to be undervalued.
The current stock price of $0.12 is trading 68.6% below its estimated GF Value™ of $0.37.
GuruFocus considers Cardiff Lexington to be Possible Value Trap.
Key valuation signals for CDIX:
Operating Cash Flow per Share: $-0.16
GF Value™: $0.37 vs. price of $0.12 (68.6% below fair value)
No single metric tells the full story. See the CDIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardiff Lexington Corp is an acquisition holding company, conducting its operations through its operating subsidiaries. The company has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The Healthcare segment generates all of the company's revenue and provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The Real estate segment consists of Edge View, a real estate company that owns various acres zoned medium-density residential.
21GF Score
Get the complete analysis for CDIX
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CDIX has been successfully added to your 
